mRNA Cancer Vaccine Breakthrough Threatened by Spreading Misinformation

For the first time, a late-stage clinical trial has successfully tested an mRNA cancer vaccine. Moderna and Merck announced that their personalized vaccine, intismeran autogene, reduced melanoma recurrence when combined with Keytruda.

This breakthrough could revolutionize cancer treatment and prevention. However, misinformation about mRNA technology is spreading on social media, threatening its potential impact.

Misinformation claims that COVID-19 mRNA vaccines cause unusually aggressive cancers, known as 'turbo cancer.' Despite a lack of credible evidence, this narrative has trickled into mainstream news outlets.

As health misinformation spreads rapidly online, it can have real-world consequences. Researchers found that inaccurate information about cancer treatment influences patient decisions and increases the risk of death.